4.4 Article

Myocardial tissue engineering

Journal

BRITISH MEDICAL BULLETIN
Volume 87, Issue 1, Pages 31-47

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/bmb/ldn026

Keywords

myocardium; infarction; tissue engineering; biomaterials

Funding

  1. Biotechnology and Biological Sciences Research Council [BB/D011027/1] Funding Source: Medline
  2. Medical Research Council [G0500373] Funding Source: Medline
  3. National Centre for the Replacement, Refinement and Reduction of Animals in Research [G0600373/1] Funding Source: Medline
  4. Biotechnology and Biological Sciences Research Council [BB/D011027/1] Funding Source: researchfish
  5. Medical Research Council [G0500373] Funding Source: researchfish
  6. National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [G0600373/1] Funding Source: researchfish
  7. BBSRC [BB/D011027/1] Funding Source: UKRI
  8. MRC [G0500373] Funding Source: UKRI

Ask authors/readers for more resources

Introduction: Regeneration of the infarcted myocardium after a heart attack is one of the most challenging aspects in tissue engineering. Suitable cell sources and optimized biocompatible materials must be identified. Sources of data: In this review, we briefly discuss the current therapeutic options available to patients with heart failure post-myocardial infarction. We describe the various strategies currently proposed to encourage myocardial regeneration, with focus on the achievements in myocardial tissue engineering (MTE). We report on the current cell types, materials and methods being investigated for developing a tissue-engineered myocardial construct. Areas of agreement: Generally, there is agreement that a 'vehicle' is required to transport cells to the infarcted heart to help myocardial repair and regeneration. Areas of controversy: Suitable cell source, biomaterials, cell environment and implantation time post-infarction remain obstacles in the field of MTE. Growing points: Research is being focused on optimizing natural and synthetic biomaterials for tissue engineering. The type of cell and its origin (autologous or derived from embryonic stem cells), cell density and method of cell delivery are also being explored. Areas timely for developing research: The possibility is being explored that materials may not only act as a support for the delivered cell implants, but may also add value by changing cell survival, maturation or integration, or by prevention of mechanical and electrical remodelling of the failing heart.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available